Lipoprotein (a) upregulates ABCA1 in liver cells via scavenger receptor-B1 through its oxidized phospholipids

Journal of Lipid Research

Volumn 56, Issue 7, 2015, Pages 1318-1328

  Sharma, Monika ^b   Von Zychlinski Kleffmann, Anne ^b   Porteous, Carolyn M ^b   Jones, Gregory T ^a   Williams, Michael J A ^a   McCormick, Sally P A ^b  

^a UNIVERSITY OF OTAGO   (New Zealand)

^b UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

Adenosine 5 triphosphate binding cassette transporter A1; Cholesterol efflux; High density lipoprotein; Nuclear receptor liver X receptor; Nuclear receptor peroxisome proliferator activated receptor

Indexed keywords

ABC TRANSPORTER A1; LIPOPROTEIN A; LIVER X RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PHOSPHOLIPID; SCAVENGER RECEPTOR BI; CD36 ANTIGEN;

ARTICLE; CHOLESTEROL TRANSPORT; CONTROLLED STUDY; HEPG2 CELL LINE; HUMAN; HUMAN CELL; LIPID METABOLISM; LIPID OXIDATION; LIPID TRANSPORT; LIVER CELL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; UPREGULATION; DRUG EFFECTS; GENETICS; HEP-G2 CELL LINE; METABOLISM; OXIDATION REDUCTION REACTION; PROTEIN TRANSPORT;

ANTIGENS, CD36; ATP BINDING CASSETTE TRANSPORTER 1; HEP G2 CELLS; HEPATOCYTES; HUMANS; LIPOPROTEIN(A); OXIDATION-REDUCTION; PHOSPHOLIPIDS; PROTEIN TRANSPORT; UP-REGULATION;

EID: 84937145417     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M056150     Document Type: Article

References (42)

1. Utermann, G. 1989. The mysteries of lipoprotein(a). Science. 246: 904-910.
2. Nordestgaard, B. G., M. J. Chapman, K. Ray, J. Borén, F. Andreotti, G. F. Watts, H. Ginsberg, P. Amarenco, A. Catapano, O. S. Descamps, et al European Atherosclerosis Society Consensus Panel. 2010. Lipoprotein(a) as a cardiovascular risk factor: current status. Eur. Heart J. 31: 2844-2853.
3. Bergmark, C., A. Dewan, A. Orsoni, E. Merki, E. R. Miller, M. J. Shin, C. J. Binder, S. Hörkkö, R. M. Krauss, M. J. Chapman, et al. 2008. A novel function of lipoprotein [a] as a preferential carrier of oxidized phospholipids in human plasma. J. Lipid Res. 49: 2230-2239.
4. Leibundgut, G., C. Scipione, H. Yin, M. Schneider, M. B. Boffa, S. Green, X. Yang, E. Dennis, J. L. Witztum, M. L. Koschinsky, et al. 2013. Determinants of binding of oxidized phospholipids on apolipoprotein (a) and lipoprotein (a). J. Lipid Res. 54: 2815-2830.
5. Chawla, A., W. A. Boisvert, C. H. Lee, B. A. Laffitte, Y. Barak, S. B. Joseph, D. Liao, L. Nagy, P. A. Edwards, L. K. Curtiss, et al. 2001. A PPAR gamma-LXR-ABCA1 pathway in macrophages is involved in cholesterol efflux and atherogenesis. Mol. Cell. 7: 161-171.
6. Hossain, M. A., M. Tsujita, F. J. Gonzalez, and S. Yokoyama. 2008. Effects of fibrate drugs on expression of ABCA1 and HDL biogenesis in hepatocytes. J. Cardiovasc. Pharmacol. 51: 258-266.
7. Miao, B., S. Zondlo, S. Gibbs, D. Cromley, V. P. Hosagrahara, T. G. Kirchgessner, J. Billheimer, and R. Mukherjee. 2004. Raising HDL cholesterol without inducing hepatic steatosis and hypertriglyceridemia by a selective LXR modulator. J. Lipid Res. 45: 1410-1417.
8. Basso, F., L. Freeman, C. L. Knapper, A. Remaley, J. Stonik, E. B. Neufeld, T. Tansey, M. J. Amar, J. Fruchart-Najib, N. Duverger, et al. 2003. Role of the hepatic ABCA1 transporter in modulating intrahepatic cholesterol and plasma HDL cholesterol concentrations. J. Lipid Res. 44: 296-302.
9. Luc, G., J. M. Bard, D. Arveiler, J. Ferrieres, A. Evans, P. Amouyel, J. C. Fruchart, and P. Ducimetiere; PRIME Study Group. 2002. Lipoprotein (a) as a predictor of coronary heart disease: the PRIME Study. Atherosclerosis. 163: 377-384.
10. Gaw, A., and H. H. Hobbs. 1994. Molecular genetics of lipoprotein (a): new pieces to the puzzle. Curr. Opin. Lipidol. 5: 149-155.
11. Marcovina, S. M., J. J. Albers, E. Wijsman, Z. Zhang, N. H. Chapman, and H. Kennedy. 1996. Differences in Lp[a] concentrations and apo[a] polymorphs between black and white Americans. J. Lipid Res. 37: 2569-2585.
12. Giger, J. N., O. L. Strickland, M. Weaver, H. Taylor, and R. T. Acton. 2005. Genetic predictors of coronary heart disease risk factors in premenopausal African-American women. Ethn. Dis. 15: 221-232.
13. Sharma, S., J. Merchant, and S. E. Fleming. 2012. Lp(a)-cholesterol is associated with HDL-cholesterol in overweight and obese African American children and is not an independent risk factor for CVD. Cardiovasc. Diabetol. 11: 10.
14. Tsimikas, S., P. Clopton, E. S. Brilakis, S. M. Marcovina, A. Khera, E. R. Miller, J. A. de Lemos, and J. L. Witztum. 2009. Relationship of oxidized phospholipids on apolipoprotein B-100 particles to race/ethnicity, apolipoprotein(a) isoform size, and cardiovascular risk factors: results from the Dallas Heart Study. Circulation. 119: 1711-1719.
15. Rodger, E. J., R. J. Suetani, G. T. Jones, T. Kleffmann, A. Carne, M. Legge, and S. P. McCormick. 2012. Proteomic analysis of aortae from human lipoprotein(a) transgenic mice shows an early metabolic response independent of atherosclerosis. PLoS ONE. 7: e30383.
16. Chen, X., Y. Zhao, Z. Guo, L. Zhou, E. U. Okoro, and H. Yang. 2011. Transcriptional regulation of ATP-binding cassette transporter A1 expression by a novel signaling pathway. J. Biol. Chem. 286: 8917-8923.
17. Liao, H., T. Langmann, G. Schmitz, and Y. Zhu. 2002. Native LDL upregulation of ATP-binding cassette transporter-1 in human vascular endothelial cells. Arterioscler. Thromb. Vasc. Biol. 22: 127-132.
18. Cain, W. J., J. S. Millar, A. S. Himebauch, U. J. Tietge, C. Maugeais, D. Usher, and D. J. Rader. 2005. Lipoprotein [a] is cleared from the plasma primarily by the liver in a process mediated by apolipoprotein [a]. J. Lipid Res. 46: 2681-2691.
19. Kraft, H. G., A. Lingenhel, F. J. Raal, M. Hohenegger, and G. Utermann. 2000. Lipoprotein(a) in homozygous familial hypercholesterolemia. Arterioscler. Thromb. Vasc. Biol. 20: 522-528.
20. Argraves, K. M., K. F. Kozarsky, J. T. Fallon, P. C. Harpel, and D. K. Strickland. 1997. The atherogenic lipoprotein Lp(a) is internalized and degraded in a process mediated by the VLDL receptor. J. Clin. Invest. 100: 2170-2181.
21. Hrzenjak, A., S. Frank, X. Wo, Y. Zhou, T. B. Van, and G. M. Kostner. 2003. Galactose-specific asialoglycoprotein receptor is involved in lipoprotein (a) catabolism. Biochem. J. 376: 765-771.
22. Yang, X. P., M. J. Amar, B. Vaisman, A. V. Bocharov, T. G. Vishnyakova, L. A. Freeman, R. J. Kurlander, A. P. Patterson, L. C. Becker, and A. T. Remaley. 2013. Scavenger receptor-BI is a receptor for lipoprotein(a). J. Lipid Res. 54: 2450-2457.
23. Havel, R. J., H. A. Eder, and J. H. Bragdon. 1955. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J. Clin. Invest. 34: 1345-1353.
24. Innis-Whitehouse, W., X. Li, W. V. Brown, and N. A. Le. 1998. An efficient chromatographic system for lipoprotein fractionation using whole plasma. J. Lipid Res. 39: 679-690.
25. Strober, W. 2001. Trypan blue exclusion test of cell viability. Curr. Protoc. Immunol. 21: Appendix 3, Appendix 3B.
26. Marcovina, S. M., J. J. Albers, B. Gabel, M. L. Koschinsky, and V. P. Gaur. 1995. Effect of the number of apolipoprotein(a) kringle 4 domains on immunochemical measurements of lipoprotein(a). Clin. Chem. 41: 246-255.
27. Williamson, K. S., K. Hensley, and R. A. Floyd. 2003. Fluorometric and colorimetric assessment of thiobarbituric acid-reactive lipid aldehydes in biological matrices. In Methods in Pharmacology and Toxicology: Methods in Biological Oxidative Stress. K. Hensley and R. A. Floyd, editors. Humana Press Inc., Totowa, NJ. 57-65.
28. Sorrenson, B., R. J. Suetani, M. J. Williams, V. M. Bickley, P. M. George, G. T. Jones, and S. P. McCormick. 2013. Functional rescue of mutant ABCA1 proteins by sodium 4-phenylbutyrate. J. Lipid Res. 54: 55-62.
29. Brace, R. J., B. Sorrenson, D. Sviridov, and S. P. A. McCormick. 2010. A gel-based method for purification of apolipoprotein A-I from small volumes of plasma. J. Lipid Res. 51: 3370-3376.
30. Krempler, F., G. M. Kostner, K. Bolzano, and F. Sandhofer. 1980. Turnover of lipoprotein (a) in man. J. Clin. Invest. 65: 1483-1490.
31. von Zychlinski, A., T. Kleffmann, M. J. A. Williams, and S. P. McCormick. 2011. Proteomics of lipoprotein(a) identifies a protein complement associated with response to wounding. J. Proteomics. 74: 2881-2891.
32. Lundstam, U., E. Hurt-Camejo, G. Olsson, P. Sartipy, G. Camejo, and O. Wiklund. 1999. Proteoglycans contribution to association of Lp(a) and LDL with smooth muscle cell extracellular matrix. Arterioscler. Thromb. Vasc. Biol. 19: 1162-1167.
33. Hofmann, S. L., D. L. Eaton, M. S. Brown, W. J. McConathy, J. L. Goldstein, and R. E. Hammer. 1990. Overexpression of human low density lipoprotein receptors leads to accelerated catabolism of Lp(a) lipoprotein in transgenic mice. J. Clin. Invest. 85: 1542-1547.
34. Reblin, T., A. Niemeier, N. Meyer, T. E. Willnow, F. Kronenberg, H. Dieplinger, H. Greten, and U. Beisiegel. 1997. Cellular uptake of lipoprotein[a] by mouse embryonic fibroblasts via the LDL receptor and the LDL receptor-related protein. J. Lipid Res. 38: 2103-2110.
35. Tsimikas, S., and J. L. Witztum. 2008. The role of oxidized phospholipids in mediating lipoprotein(a) atherogenicity. Curr. Opin. Lipidol. 19: 369-377.
36. Niemeier, A., T. Willnow, H. Dieplinger, C. Jacobsen, N. Meyer, J. Hilpert, and U. Beisiegel. 1999. Identification of megalin/gp330 as a receptor for lipoprotein(a) in vitro. Arterioscler. Thromb. Vasc. Biol. 19: 552-561.
37. Miles, L. A., G. M. Fless, A. M. Scanu, P. Baynham, M. T. Sebald, P. Skocir, L. K. Curtiss, E. G. Levin, J. L. Hoover-Plow, and E. F. Plow. 1995. Interaction of Lp(a) with plasminogen binding sites on cells. Thromb. Haemost. 73: 458-465.
38. Gillotte-Taylor, K., A. Boullier, J. L. Witztum, D. Steinberg, and O. Quehenberger. 2001. Scavenger receptor class B type I as a receptor for oxidized low density lipoprotein. J. Lipid Res. 42: 1474-1482.
39. Beisiegel, U., W. Weber, G. Ihrke, J. Herz, and K. K. Stanley. 1989. The LDL-receptor-related protein, LRP, is an apolipoprotein E-binding protein. Nature. 341: 162-164.
40. Taleb, A., J. L. Witztum, and S. Tsimikas. 2011. Oxidized phospholipids on apoB-100-containing lipoproteins: a biomarker predicting cardiovascular disease and cardiovascular events. Biomark. Med. 5: 673-694.
41. von Zychlinski, A., M. Williams, S. McCormick, and T. Kleffmann. 2014. Absolute quantification of apolipoproteins and associated proteins on human plasma lipoproteins. J. Proteomics. 106: 181-190.
42. Kraft, H. G., H. Dieplinger, E. Hoye, and G. Utermann. 1988. Lp(a) phenotyping by immunoblotting with polyclonal and monoclonal antibodies. Arteriosclerosis. 8: 212-216.